Skip to main content
Loading

Current challenges for drug substance CDMOs in the Oligonucleotide space

30 Oct 2024
Manufacturing
Current challenges for drug substance CDMOs in the Oligonucleotide space
  • What are the timeline and scale expectations?
  • What is important when selecting your CMO?
  • How important is innovation and the move towards greener processes?
Industry Experts
Trishul Shah, Director Business Development, Head of Sales North America - PolyPeptide